Novartis’ Bid to Block Missouri’s Drug Discount Law Rejected

Novartis AG failed to show that it will suffer harm from a Missouri law that requires it to discount drugs to an unlimited number of pharmacies under the 340B Drug Pricing Program, a federal judge ruled.

An order issued Monday by Judge Douglas Harpool of the US District Court for the Western District of Missouri ruled that Novartis hasn’t shown “more than a mere possibility of irreparable harm,” or a substantial likelihood of success on the merits to be granted a preliminary injunction against Missouri’s law (S.B. 751).

“Plaintiff has failed to prove their harm is anything more ...